Archives
-
Deferasirox Fe3+ Chelate: Lab Workflow
2026-10-01
Build reproducible iron-overload assays around a defined ferric chelate rather than relying on poorly controlled aqueous dosing. This workflow combines DMSO-compatible preparation, orthogonal iron and toxicity readouts, and translational guardrails for beta-thalassemia and chronic anemia research.
-
Haloprogin: Findings from a 1970 Antifungal Study
2026-10-01
The 1970 study positioned Haloprogin as a topical antifungal with dermatophyte activity comparable to tolnaftate, while revealing additional activity against Candida species and selected Gram-positive bacteria. Its combined serial-dilution, fungicidal, serum-effect, and guinea pig infection experiments provide a useful framework for interpreting spectrum, formulation, and translational limitations.
-
Primidone and CYP19: Evidence from an Antiepileptic Study
2026-09-30
The reference study systematically examined whether 12 antiepileptic drugs inhibit human aromatase (CYP19), linking in vitro enzyme activity to possible steroid-hormone effects. Primidone, also known as Mysoline, showed no detectable CYP19 inhibition in the tested system, whereas several other drugs inhibited aromatase and selected combinations produced additive effects.
-
2'3'-cGAMP: Reframing STING Translation
2026-09-30
2'3'-cGAMP is more than a canonical STING agonist: it is a precision probe for separating cGAS activation, cGAMP transport, and STING competence. This article translates recent evidence on ABCC10-mediated cGAMP efflux and radiotherapy resistance into an experimental strategy for immunotherapy and cancer researchers.
-
PX-478 2HCl: Reliable HIF-1α Assays
2026-09-29
A scenario-driven guide to using PX-478 2HCl (SKU B6004) in viability, proliferation, cytotoxicity, hypoxia, and radiosensitization workflows. It connects product parameters with controls, interpretation, cross-model limitations, and practical vendor-selection criteria.
-
MVC Activates RhoA/ROCK1/MLC2 to Disrupt Tight Junctions
2026-09-29
Ren and colleagues identify a previously uncharacterized entry mechanism in which MVC VP2 interacts with ROCK1 and activates the RhoA/ROCK1/MLC2 axis, remodeling tight junctions in WRD cells. The study connects actomyosin contraction, Occludin redistribution, and viral replication, providing a mechanistic basis for investigating host-directed anti-MVC strategies.
-
Azathramycin A in TB Ribosome Research
2026-09-28
Azathramycin A supports a practical bridge between cell-free ribosome-binding studies and Mycobacterium tuberculosis infection model research. This workflow-focused guide covers solvent handling, orthogonal mechanism-of-action assays, degradation monitoring, and troubleshooting for reproducible antibacterial agent for tuberculosis research.
-
HyperPFU™ high-fidelity DNA polymerase: PCR Guide
2026-09-28
HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, or otherwise difficult DNA templates, with blunt-ended products suited to cloning and sequencing workflows. It is not the right choice when a PCR product must carry 3′-A overhangs or sticky ends; plan to add the required end structure using a separate, validated step.
-
Primary Antibody Dilution Buffer for PCNSL Assays
2026-09-27
Translate single-cell findings on SLC2A5-mediated fructose metabolism into practical protein-localization experiments with a buffer designed for primary-antibody preparation. This workflow highlights how to optimize staining in challenging CNS lymphoma samples—while keeping immunostaining evidence distinct from metabolic-function claims.
-
Suhuang Suppresses ER Stress–Linked NLRP3 in CVA
2026-09-26
In an ovalbumin-induced cough variant asthma model, Suhuang antitussive capsule improved pulmonary dysfunction while reducing endoplasmic reticulum stress and NLRP3 inflammasome activation. The study’s pharmacological perturbations support a role for ER stress and a TXNIP–RIP1/RIP3–Drp1 axis in connecting cellular stress to inflammatory signaling, although the findings remain preclinical.
-
Baicalein Workflows for Cancer and Inflammation Studies
2026-09-25
Use Baicalein to probe 12-LOX-linked arachidonic acid metabolism, inflammatory signaling, and cancer-cell responses with dose-controlled, vehicle-matched workflows. A neurotoxicity study offers a useful model for separating protective effects from anticancer activity—but its findings concern formononetin, not Baicalein.
-
Stromal Remodeling Nanomedicine for Pancreatic Cancer
2026-09-25
This study reports an acid-responsive, sequential-release nanomedicine designed to remodel pancreatic tumor stroma before delivering gemcitabine. In a mouse model, the combined formulation was associated with marked tumor regression, supporting further investigation of stromal normalization as a way to improve drug access while leaving clinical efficacy unestablished.
-
Deferasirox Fe3+ Chelate in Iron Overload Research
2026-09-24
Build iron-handling experiments around the ferric complex itself—not assumptions about the unbound oral chelator. This guide translates clinical context into controlled workflows, solvent-aware handling, and practical checks for beta-thalassemia and chronic anemia models.
-
NF 449: Purinergic Receptor Antagonist in Platelet Studies
2026-09-24
NF 449 helps researchers isolate ATP-driven P2X1 signaling from other platelet purinergic responses, making it useful for mechanistic platelet activation and thrombosis studies. Its nanomolar recombinant-receptor potency requires careful translation into native platelet assays, where concentration, agonist choice, and receptor desensitization all matter.
-
Netrin-1 Disrupts Adipogenesis in Obesity
2026-09-23
A 2026 Communications Biology study links adipose-derived Netrin-1 to impaired adipocyte differentiation and metabolic dysfunction, implicating reduced PPARγ activity and increased Wnt/β-catenin signaling. Genetic loss- and gain-of-function experiments suggest that the quality of adipose remodeling—not simply total body weight—can shape glucose regulation during dietary excess.